> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
> See specialized channels

  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter

AMSilk to Be Featured on 21st Century Business Television on CNBC and Fox Business Network

| Print |
Thursday, 26 January 2012 11:00 (UTC + 1)


Munich, Germany,  January 26,  2012 / B3C newswire / - AMSilk is pleased to announce that the company will be featured in the 21st Century Business series on Fox Business Network this week, Saturday the 28th of January at 4:30 pm ET (3:30 CT, 2:30 MT, 1:30 PT) .
The week’s segment on AMSilk’s Innovative High Performance Spider Silk Materials.

AMSilk CEO, Axel Leimer explains the company’s award winning technology, copying one of nature’s most coveted high-performance materials, spider silk, with a commercial production process, to studio host Jackie Bales. The show takes a look at AMSilk’s laboratories in Germany, current upscaling efforts and new products in development.

The show aired on CNBC on the 24th and 25 th of January.

Use the following link to see the show on Youtube:


About AMSilk
Spider silk has attracted human interest for thousands of years, mainly due to its toughness and ductility. The material is also biocompatible and can be used in formulations for specialized coatings, films, nonwovens and in pharmaceuticals. As with most biomaterials, spider silk has evolved over millions of years resulting in a combination of properties that far exceeds any man-made material. Until recently, it was not possible to utilize this high-performance material for technical applications, because no process was known to produce enough spider silk. AMSilk is the first company to produce Spidersilk biopolymers, inspired by the proteins of web-weaving spiders on an industrial scale. This makes possible a completely new set of technical products as well as major improvements for already existing products. AMSilk, a spin-off from the Technische Universität München, was founded in 2008 and is located in the IZB in Martinsried near Munich. AMSilk’s investors are MIG Funds and AT Newtec, Munich. For more information visit the website at www.amsilk.com. AMSilk and Spidersilk are registered trademarks in the European Union and trademark applications in the USA of AMSilk GmbH, Germany.

Axel H. Leimer  
Managing Director
AMSilk GmbH
Am Klopferspitz 19 im IZB
82152 Planegg/Martinsried, Germany
Tel: +49 (0)89 38156-4430
Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it